Background: Lymphedema is a common and debilitating complication following cancer treatment with surgical lymph node excision and radiotherapy. Currently there are no curative treatments for lymphedema. Animal models that intended to replicate the disease have been inadequate, making a troublesome transition from experimental therapeutic studies into the clinic. It is therefore imperative to establish an experimental animal model that can reliably replicate clinical lymphedema. Methods: To discover the optimal method of lymphedema induction, surgical lymph ablation and irradiation or silicone splint emplacement were combined in 8 experimental groups (n = 4). In total, 32 mice served in this study and were followed for 8 weeks after surgery. Outcomes included micro-computed tomography hind limb volumetry, lymphatic clearance measured with technetium Tc 99m (
L ymphedema is a frequent adverse effect following cancer treatment with lymph node involvement and adjuvant radiotherapy. 1 The condition is a complex composition, characterized by chronic tissue swelling, inflammation, and inhibited lymph flow, which makes the disease unsuitable for in vitro studies. Despite the importance and prevalence of the disorder, our knowledge about the underlying pathophysiology is sparse, and development of treatment modalities is hampered by the lack of reliable animal models. 2 Rodents have always been a preclinical cost-efficient platform for studying diseases, but several shortcomings of current lymphedema models are hindering progress into the clinic. 3 The rodent tail lymphedema model has been used by several authors because of the ease of the procedure 4 ; however, the rodent tail lacks lymph nodes and differs from the human limb in essential physiological and anatomical properties. Rodent models of limb lymphedema represent a closer representation and have previously been sought established by a combination of surgical lymph node ablation and a single high dose of irradiation 5, 6 or a silicone splint emplacement. 7 However, these methods have been subject to severe morbidity or spontaneous lymphedema resolution, which is not reflected in the disease seen in humans. 3 Irradiation therapy is a known inducer of lymphatic injury, but an optimal dose titration for induction of preclinical lymphedema has yet to be uncovered.
Thus, our aim was to develop a clinical relevant lymphedema hind limb model and methods for objective quantification. Built upon the limitations of previous models, we propose a refined lymphedema model established with combined lymphadenectomy and fractioned irradiation.
METHODS
All experiments were conducted in accordance with national and institutional guidelines for the care and use of animals in research. This study was approved by the Danish National Animal Inspectorate (2016-15-0201-00909) and reported according to the Animal Research: Reporting In Vivo Experiments guidelines. 8 
Study Design
In this experimental study, lymphedema was induced in the right hind limbs of mice, whereas the left hind limb served as an internal control ( Fig. 1) . Eight treatment groups of 4 mice per group served in this study. All groups underwent surgical ablation of lymphatic drainage paths. Six of these groups received ionized radiation therapy in 1 or 2 fractions (range, 7.5-30 Gy). One group received no irradiation; however, a silicone splint was implanted between wound edges, and finally 1 group received surgical lymphatic obstruction only. All mice underwent weekly micro-computed tomography (μCT) scans of the operated and unoperated limbs for repetitive volume assessments up until the eighth week after the surgical procedure. At the fourth week, 2 mice from each group underwent technetium Tc 99m human serum albumin ( 99m Tc-HSA) lymphoscintigraphy. At the end of the study, all mice were killed, and hind limbs from 3 mice in each group were dissected for immunohistochemistry and assessment of lymphatic vessel ectasia in the dorsal footpad.
Animals
In total, thirty-two 9-week-old female inbred C57BL/6 mice weighing between 19 and 23 g were purchased from Taconic Biosciences (Ejby, Denmark). All mice were acclimatized for 7 days in groups of 4 per cage after arrival. All animals were maintained on a normal 12-hour day-night cycle at 21°C with a humidity of 45% to 55% and fed a standard diet with unrestricted access to water.
Experimental Procedure
One investigator performed all experimental procedures. All animals were anesthetized by a subcutaneous injection of fentanyl 788 μg/kg, fluanisone 25 mg/kg, and midazolam 12.5 mg/kg.
Surgery
A previous method of lymphatic tissue ablation in the mouse hind limb was adapted. 5 Briefly, a circumferential incision was made proximal on the midthigh area. After a subcutaneous injection of 0.1 mL patent blue V to the right second and third toe, a postnodal lymphatic vessel was easily identified along the ischiatic vein. Then, the skin was bluntly dissected just distal to the knee, and a blue-stained popliteal lymph node and 2 prenodal lymphatic vessels were macroscopically identified. Stained prenodal and postnodal lymphatics were tied with 10-0 nylon suture, and blockage was confirmed with a careful milking test (Fig. 2) . During the procedure, care was taken not to injure the ischiatic vein. Afterward, the popliteal and inguinal lymph nodes were resected along with their respective fat pads. Finally, the procedure was concluded with a circumferential suturing of the skin edges down to the muscle fascia with 6-0 nylon, leaving a wound gap of 2 mm to constrain the superficial lymph flow. Postoperatively, mice were housed individually and received subcutaneous injections with 0.02 mL buprenorphine 3 times daily for 3 days.
Radiation
Radiation was emitted from a Gulmay D3100 x-ray machine (Xstrahl, Camberley, United Kingdom) at a dose rate of 5.11 Gy/min (100 kVp, 10 mA, HVL 2.53 Al). Treatment was given at 1 or 2 fractions ranging from 7.5 to 30 Gy, depending on group allocation. The irradiated area (25 mm Ø) was enclosed by 1.5-mm-thick lead rubber.
Silicone Splint
In the silicone splint group, a 3-mm-wide rectangular silicone splint was cut from a 1-mm-thick silicone sheet (Aalborg Gummivarefabrik A/S, Aalborg, Denmark). Mice allocated to the silicone group had the splint sutured to the inside of the inguinal wound and fixated between the skin edges and underlying muscle fascia during surgery. 7 
Soft Tissue and Skin Breakdown Assessment
Operated hind limbs were scrutinized weekly for any signs of skin breakdown, nonhealing wounds, wound necrosis, and/or wound oozing.
Computed Tomography and Single-Photon Emission Computed Tomography Lymphoscintigraphy
Small-animal single-photon emission computed tomography (SPECT)/CT was performed on a Siemens INVEON multimodality preclinical scanner (Siemens Preclinical Solutions, Knoxville, Tenn). During each imaging session, mice were anesthetized with a mixture of 1.5% to 2.0% isoflurane and 100% oxygen and placed in a prone position on a heated SPECT/CT animal bed (38 mm).
To assess the lymphatic clearance, mice received a subcutaneous bolus injection of 0.02 mL Tc-HSA between the second and third toe of each hind paw. Doses were approximately 25 MBq (Vasculocis; CIS Bio International, Paris, France) and administered using a 0.5 mL 30-gauge insulin syringe (Covidien; Medtronic, Minneapolis, Minn). The tracer uptake was assumed to have reached steady state after 45 minutes. 9 Mice underwent SPECT/CT at 45 minutes and 4 hours after injection of 99m Tc-HSA and moved around freely between imaging sessions.
Computed tomography scans were performed with the following settings; 360°rotation with 360 projections. The magnification was set at low-medium with a binding factor of 2 Â 2, yielding an isotropic pixel size of 47.83 μm and a transaxial field view of 49 mm. Tube voltage was set to 80 kV, current was 500 μA, and each projection was exposed for 950 milliseconds. Computed tomography scans were reconstructed using Feldkamp algorithm, with Shepp-Logan filter and slight noise reduction. SPECT images were acquired using mouse whole body pinhole collimators (5 pinholes). A full 360°rotation with 60 projections and fixed radius of 30 mm yielded a reconstructed image of 38-mm transaxial field of view. A 20% energy window centered on the energy peak of 99m Tc at 140 keV was used. Acquisition duration was set to 10 seconds per projection in the early scan and 30 seconds per projection in the late scan. Computed tomography and SPECT images were coregistered using a transformation matrix, and SPECT data were reconstructed using Siemens MAP3D algorithm (128 Â 128 matrix, 0.5-mm pixels, 16 iterations, and 6 subsets).
Analysis
Data analysis of the SPECT/CT fused images was performed with the INVEON Research Workplace software, version 4.2 (IRW; Siemens Healthcare, Ballerup, Denmark). Volumes of interest were defined around each injection site. Care was taken to include all activity in the hind limb. The activity decline from the injection site was assumed to follow a monoexponential function e -kt . The removal rate was calculated as 100%k (%/min).
Volumetric measures of hind limbs were calculated from acquired CT images. The distal tibiofibular joint was localized in 3-dimensional (3D) axial images using a previously described method 10 and functioned as the upper volumetric boundary limit. The hind limb distally from the tibiofibular joint was then defined using the regionof-interest function in Siemens IRW software (Fig. 3 ).
Lymph Vessel Immunohistochemistry
Hind limbs were fixed in 4% paraformaldehyde for 48 hours. Afterward, the feet were cut 10 mm distal to the heel and decalcified in 4.0 M formic acid/0.5 M sodium formate for 4 hours before paraffin embedding. To detect lymphatic vessels, 3-μm-thick sections were obtained from the cut surface and stained using anti-LYVE-1 (ab33682; Abcam, Cambridge, United Kingdom) as primary antibody was used. Antigen retrieval was achieved by Tris-EDTA buffer (pH 9.0) microwaving for 15 minutes at 440 W. Specimens were incubated with primary antibody (1:1000) for 60 minutes at room temperature. Envision + horseradish peroxidase-labeled polymer (K4003; Dako, Agilent, Glostrup, Denmark) was used as detection system.
Analysis
Sectioned images were obtained using NanoZoomer 2.0-HT digital Slide Scanner and analyzed in Visiopharm Vision software version 2017.1 (Visiopharm Vision, Hoersholm, Denmark). For each sectioned image, the region of interest was within the dorsal footpad area bounded laterally by the 3 middle metatarsals. The area was enclosed manually in 2 dimensions using the image analysis region-of-interest function, and FIGURE 3. High-resolution 3D μCT scans for limb volume assessment. Presented is the lower extremity of one mouse in the 2 Â 10 Gy group, 8 weeks after lymphedema was induced. At this point, the lymphedemateous limb (left side on figure) is retaining more than 20% increased volume compared to the control limb (right side on figure). The distal tibio-fibular joint was used as a proximal landmark, and the limb volumes distally for this boundary were calculated. the lumens of all stained lymphatic vessels inside the area were manually enclosed using point counting. 11 The areas within the region of interest occupied by lymphatic vessels were for each foot automatically calculated by Visiopharm Vision software.
Statistical Analysis
All data were analyzed using STATA 14 (Stata Statistical Software: Release 14. College Station, Tex: StataCorp LP; 2015) and Prism 6.0 (GraphPad Software, La Jolla, Calif ). A paired design using 2-way analysis of variance test was used to compare operated and control hind limbs within each group with Sidak's multiple-comparisons test. Sidak's multiple comparison was used for comparing operated and unoperated limbs of the animals in each experimental group at each time point. All values are reported as a mean ± SD. A 2-tailed P < 0.05 was considered significant.
RESULTS

Skin Breakdown and Adverse Events
Mice in the 1 Â 20 Gy group developed various degrees of soft tissue and skin breakdown after 3 weeks, and all mice in the 2 Â 15 Gy, FIGURE 4. Adverse soft tissue events and limb volumes from each week extracted from μCT scans. Graphed over time are the mean volume and SD of the operated hind limbs in each experimental group. For illustrative purposes, the control group comprised all unoperated limbs. Photographs in the top left quadrant represent adverse soft tissue events in the 4 experimental groups with adverse tissue events. Photograph in the bottom right quadrant depicts a representative edematous hind limb in the 2 Â 10 group after 8 weeks of follow-up. n.s. Indicates no statistically significant volumetric difference to internal control limbs at any time point.
Statistically significant volumetric difference of P < 0.05 from internal control limbs during the first 2 weeks.*Statistically significant volumetric difference of P < 0.001 from internal control limbs during the entire follow-up. Tc-HSA lymphoscintigraphy performed 4 weeks after surgical lymph ablation. The SPECT/CT images were obtained 45 minutes and 4 hours after tracer injection. Tracer uptake can be seen in lymph nodes, bladder, and intestine. Subcutaneous lymph stasis and backflow are extensively visible in the right hind limbs in the 2 Â 10 Gy group and to a lesser extent in the silicone, 2 Â 7.5 Gy, and 1 Â 20 Gy groups. Diffuse lymph stasis in the right footpad is visible in the 2 Â 15 Gy, 2 Â 20 Gy, and 1 Â 30 Gy groups. No lymph backflow or diffuse stasis is visible in the surgery-only group or in any of the unoperated left hind limbs, which served as internal controls with intact popliteal and inguinal lymph nodes. Brighter colors denote greater intensity.
2 Â 20 Gy, and 1 Â 30 Gy groups developed severe soft tissue and skin breakdown after 2 weeks (Table 1) . After consultation with the local laboratory of animal science veterinarian, all mice were kept alive and received daily analgesic (carprofen 2 mg/kg); however, no mice underwent spontaneous wound healing. No mice in the remaining groups (surgery only, silicone splint, 2 Â 7.5 Gy, and 2 Â 10 Gy) developed any adverse complications. In groups without adverse complications, the skin gap healed uneventfully by the second week of follow-up. In the silicone group, the implanted silicone splint was separated from the wound in all mice at the second week of follow-up.
Limb Volumes
All operated limbs presented with initial postoperative swelling (Fig. 4) . Hind limbs in the surgery-only group had a nonsignificant limb enlargement at week 1, which recovered spontaneously after the second week. Operated limbs in the silicone splint and 2 Â 7.5 Gy groups had significantly higher volumes than their control limbs during the first 2 weeks of follow-up, but the effect was lost at the third week. The 2 Â 10 Gy, 1 Â 20 Gy, and 1 Â 30 Gy groups maintained a relatively constant excessive volume during the entire follow-up. In the 2 Â 10 Gy group, the lymphedematous limbs retained a mean excessive volume of 28.7% ± 3.8% at the eighth week of follow-up. Groups that received high irradiation dosages in 2 fractions, 2 Â 15 Gy and 2 Â 20 Gy, showed a progressive increase in excessive volume at each following week.
Lymphoscintigraphy
Lymphatic clearance was calculated for operated and unoperated limbs derived from lymphoscintigraphy scans taken 45 minutes and 4 hours after tracer injection (Fig. 5) . Lymphatic imaging revealed that mice irradiated with 2 Â 10 Gy had severe lymphatic backflow with lymph stasis distally to the operated site. To a lesser extent, some backflow was noticiable in the silicone group and groups irradiated with 2 Â 7.5 Gy and 1 Â 20 Gy. Mice in the 2 Â 15 Gy, 2 Â 20 Gy, and 1 Â 30 Gy groups showed patterns of lymph stasis in the footpad, likely due to circumferential soft tissue necrosis proximal of the ankle. No lymph backflow was visible in the surgery-only group or the unoperated left hind limbs.
Quantification of lymphatic clearance showed a significantly inhibited lymph flow in the 2 Â 10 Gy, 1 Â 20 Gy, 2 Â 15 Gy, 2 Â 20 Gy, and 1 Â 30 Gy irradiated groups (Fig. 6) . Mice in the silicone and 2 Â 7.5 Gy groups had a statistically nonsignificant difference in lymph clearence. The surgery-only group had no statistical difference between their operated and unoperated limbs.
Immunohistochemistry
Lymph vessel dilation was assessed with LYVE-1 immunohistochemistry of the dorsal footpad, in the experimental groups with and without soft tissue breakdown (Fig. 7) . Lymph vessel lumens in the groups without soft tissue breakdown were significantly enlarged in the 2 Â 10 Gy group, whereas the cumulative lymphatic lumens in the surgery-only, silicone, and 2 Â 7.5 Gy groups matched the lumen in their respective internal control limbs (Fig. 8A) . The ratio of lymph vessel lumen inside the region of interest was significantly enlarged in the 2 Â 10 Gy group (Fig. 8B) . In the surgery-only, silicone, and 2 Â 7.5 Gy groups, the lymphatic lumen-to-soft tissue ratios were corresponding to their control limbs.
Experimental groups with adverse skin breakdown, group 2 Â 15 Gy, 2 Â 20 Gy, and 1 Â 30 Gy, had grossly and statistically significant dilation in lymph vessel lumen compared with internal control limbs, whereas the difference in the 1 Â 20 Gy group was nonsignificant (Fig. 9A ). In the lymphedemateous limbs, the enlarged lymphatic vessel lumen constituted a relative greater area of the total subcutaneous tissue compared with the control limbs in the 2 Â 15 Gy, 2 Â 20 Gy, and 1 Â 30 Gy groups (Fig. 9B) . Following a similar pattern, the lymph vessel-to-soft tissue ratio was nonsignificant in the 1 Â 20 Gy group. Examination of the sections for inflammatory cells revealed no inflammation.
DISCUSSION
In this study, we evaluated the efficacy of 8 experimental lymphedema mouse hind limb models over the course of 8 weeks. Lymphedema was induced by surgical ablation of lymphatics in combination with either irradiation or with a silicone splint. Low irradiation dosages provided no lasting lymphedema beyond the acute postoperative phase, and higher irradiation dosages resulted in lasting lymphedema but with adverse soft tissue necrosis. We were Tc-HSA tracer injection at the fourth week of follow-up. After the tracer uptake reached steady state, clearance was calculated from 45-minute and 4-hour scans and compared between operated and unoperated limbs. ns Indicates not significant. *Significant difference of P < 0.05 between operated and control limbs. **Significant difference of P < 0.001 between operated and control limbs. unable to reproduce lasting lymphedema using the silicone splinted model. 7 In this study, the balance between desired lymphedematous outcomes and adverse events was achieved by combining surgical lymph resection with preoperative and postoperative irradiation of 10 Gy. Thereby, a simple refinement of existing methods resulted in excessive volume, impaired lymphatic transport, and ectatic lymph vessels over the course of 8 weeks, without any severe complications such as nonhealing wounds (Table 2) .
Irradiation therapy is known to inhibit wound healing and potentially also the surgically induced inflammatory response.
12-14 A single fraction of preoperative high-dose irradiation has resulted in extensive morbidity, 5, 15 and there has been a need for titration of adequate radiation dosage. 16 In this study, we combined a reduced fraction of preoperative and postoperative irradiation, with the aim of compromising lymphatic revascularization, while maintaining soft tissue architecture. We conducted a series of experiments, to find the optimal irradiation dose and fraction to induce lasting lymphedema without adverse tissue breakdown. Our results confirm the previous findings that surgery alone is insufficient in inducing lasting edema, 6, 17 and high-dose irradiation causes unacceptable soft tissue morbidity. 6, 16, 18 Lymphedema is caused by reduced lymph drainage capacity, and therefore previous models have stressed the importance of evaluating lymph drainage function. Previous lymphedema models have advocated the use of photodynamic eye and indocyanine green lymphography for identification of dermal backflow patterns. While indocyanine green lymphography has a high sensitivity and specificity for lymphedema staging in the clinic, it does not provide a quantitative measure for the functional lymphatic flow. 19 In this study, we monitored lymphatic flow patterns using 99m Tc-HSA lymphoscintigraphy after the tracer reached steady state. In addition, we calculated a numeric measure for the lymphatic pumping system, by determining the mean tracer clearance between 2 time points.
Circumference measurements are routinely used for diagnosing lymphedema in the clinic 20 ; however, any manual measurement is prone to bias, especially in the setting of small-size animals. In previous animal models, edema has usually been quantified using water displacement, clippers, or a circumference assessment. 3 In this study, bias was minimized by quantifying the swelling using a predefined highresolution 3D volumetry setup. 10 Immunohistochemical staining of lymph vessels is also commonly effectuated in preclinical lymphedema research, to demonstrate lymph vessel dilation in the subcutaneous tissue secondary to lymph stasis. Lymph vessel immunoreactivity is usually quantified by the sheer number or by a 1-dimensional lymph vessel diameter assessment prepared from cross-section samples of the footpad, 7, 15, 16 but with no clear definition of the inspected cross-section area. In this study, we defined a region of interest with clear bone segment boundaries. Thus, lymphatic endothelia in 2 dimensions could reliably be identified and lumen quantified regardless of soft tissue edema. A 2-dimensional quantification of lymph vessels is further appropriate, to discriminate between collapsed and dilated vessels. In lymphedematous tissue sections, we found that lymph vessel lumen covered an exponentially larger ratio of the soft tissue area than sections from controls and unedematous groups. The ectatic lumens are likely caused by lymph stasis and not increased lymph ejection, as lymph vessel lumen and lymph clearance were not correlated. In lymphedema, inflammation has been found to facilitate fibrosis and adipose deposition, thus worsening lymphedema. 21 Other preclinical studies have linked the inflammatory cascade to obesity, 22, 23 which is supported by an absence of inflammation in our study. These findings may provide ground for future studies to enlighten the pathophysiology of lymphedema progression.
Preclinical research provides an indispensable platform for studying potential lymphedema treatments, before they are introduced FIGURE 7. Depiction of the immunohistochemical analysis of lymph vessels 8 weeks after surgery. Representative images of LYVE-1-stained lymphatic vessels in a paraffin-embedded cross section from the dorsal footpad. Lymph vessel dilation increased with higher irradiation dosages. Unoperated control limbs and surgery-only, silicone, and 2 Â 7.5 Gy operated limbs cross sections were predominated with collapsed lymph vessels. Black scale bar represents 100 μm.
to the clinic. However, it is of importance to conduct such studies in animal models that reliably replicate the human disease. Inguinal and popliteal lymphosomes have been identified as primarily responsible for the lymphatic drainage of the lower limb, 24 emphasizing the importance of disrupting both pathways when replicating the 2 Â 10 Gy animal model. Tissue compositions in humans and rodents are inherently different, as rodents heal primarily by contraction and lack subcutaneous fat. To promote wound healing by reepithelialization in rodents, a temporary skin gap is often needed to mimic the human wound healing process. 25 Previous studies that have inspected a lesser invasive approach for preclinical lymphedema by not implementing a temporary skin gap have shown less edema. 18, 26 In these studies, lymphedema was defined as a 5% relative increase in limb volume, measured between the ankle and hip joint, which was achieved in 80% of cases. While the studies were one of the early adapters of μCT for lymphedema assessment, the measured area is unreliable. Rodents are loose-skinned animals at their core and proximal extremities, 27, 28 making any cross-section cutoff in the inguen at risk of including tissue associated with the abdominal and pelvic area. Because of inevitable soft tissue sliding within this region, measurements are further variable on the degree of rotation, abduction, and flexion of the hip, contrasted to a more reproducible landmark such as the distal tibiofibular joint. 10 In our 2 Â 10 Gy model, greater than 20% excessive volume was achieved in 100% of cases and measured with reliable methods. Recent lymphedema mouse studies have opted for follow-up periods of 4 weeks or less, 7, [29] [30] [31] [32] as preclinical lymphedema has been known to progressively fade over time. In this study, follow-up time was 8 weeks, and lymphedema had been stable over the course of several weeks without signs of withdrawal. While longer follow-ups are always encouraging, the advantage of further follow-up would not offset the ethical burden in animal research. 33 The greatest obstacles in preclinical and clinical lymphedema studies lie in the definition of lymphedema and in the deficiency of standardized and objective measures. In humans, limb lymphedema can be symptomatic and diagnosable at only a 5% increase in circumference to the unaffected limb 1 ; however, in a preclinical research setting, a greater relative difference is often needed to investigate the FIGURE 8. Immunohistochemical assessment of lymph vessels in the experimental groups without skin breakdown. Cross sections were taken 10 mm from the heel, and lymph vessels were stained with LYVE-1 antibody. Lymph vessels were quantified in 2 dimensions by point counting in the dorsal footpad area, defined by the 3 middle metatarsals. A, Absolute area represented by lymphatic endothelia and vessel lumen for each experimental group. B, Depiction of the total immunohistochemical area of interest and lymph vessel lumen ratio for each experimental group. ns Indicates not significant. **Significant difference of P < 0.001 between operated and control limbs.
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Chronic Lymphedema in a Mouse Model potencies of potential treatments. In preceding studies with sufficient follow-up and absence of morbidity, lymphedema has been only transient or marginally detectable in the 5% range with biased volumetric and circumferential measurements. 3, 18, 26 In this study, titration of radiation showed that 2 fractions of 10 Gy irradiation resulted in the model retaining greater than 20% increased volume without concurrent adverse events. Reliable and reproducible outcome measurements further resulted in a low SD and statistical significance across all domains in the 2 Â 10 Gy model using a limited number of animals. Hence, the 2 Â 10 Gy model is a refinement of previous works, in that no serious morbidity was observed and allows for lymphedema to be consistently quantifiable with a reduced number of animals. 33 While the described mouse model shares many of the key clinical lymphedema characteristics, the etiology of the condition is different to the long-term onset seen in humans. 34 As rodents primarily heal by contraction and humans by re-epithelialization, 35 no lymphedema rodent model can resemble the human condition perfectly. We believe this deviation is somewhat insignificant, as the purpose of the model is to provide a platform for studying the course of lymphedema and potential treatments before they are trialed in the clinic. Injectable agents and tissue transplants are prominent lymphedema treatment modalities, 36, 37 and preclinical research is needed to unveil the underlying mechanisms of a potential therapeutic response.
CONCLUSIONS
In this study, we objectively evaluated several experimental lymphedema models over 8 weeks and found that only the 2 Â 10 Gy irradiation model retained lymphedema without unacceptable soft tissue necrosis. In addition to the implementation of a standardized volume assessment, this article further details objective methodologies for quantification of lymph flow and lymph vessel immunohistochemistry. These methodologies elucidate essential aspects of lymphedema, which can aid in the clinical translation of future studies. Similarly, the refined lymphedema mouse model can be used for future observational and interventional studies with clinical implication.
FIGURE 9.
Immunohistochemical assessment of lymph vessels in the experimental groups with skin breakdown. Cross sections were taken 10 mm from the heel, and lymph vessels were stained with LYVE-1 antibody. Lymph vessels were quantified in 2 dimensions by point counting in the dorsal footpad area, defined by the 3 middle metatarsals. A, Absolute area represented by lymphatic endothelia and vessel lumen for each experimental group. B, Depiction of the total immunohistochemical area of interest and lymph vessel lumen ratio for each experimental group. ns Indicates not significant. **Significant difference of P < 0.001 between operated and control limbs. For volumetric, lymphoscintigraphic and immunohistochemical outcomes: dark gray = significant difference from baseline; light gray = no significant difference from baseline. For evaluation of adverse soft tissue events: dark gray = no soft tissue breakdown or non-healing wounds; light gray = adverse soft tissue and skin breakdown at or before 3 weeks of follow up. The 2 Â 10-Gy group was the only group that had continuous excessive limb volume, inhibited lymph flow, and dilated lymph vessels without tissue necrosis. All remaining groups had a mixture of favorable and unfavorable outcomes.
